πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 783 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 9334522

Agents and methods to elicit anti-tumor immune response

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue May 10 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 05 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9303080

Codon optimized IL-15 and IL-15R-alpha genes for expression in mammalian cells

The United States of America as Represented by The Secretary of the Department of Health and Human Services National Institutes of Health Office of Technology Transfer Β· Granted Tue Apr 05 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 31 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9296729

Low molecular weight thyroid stimulating hormone receptor (TSHR) agonists

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Mar 29 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 24 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9284356

Identification of a west nile virus CD4 T cell epitope and use thereof

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Mar 15 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 10 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9279019

Human monoclonal antibodies specific for CD22

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Mar 08 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 03 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9279009

FILIP1L nucleic acid fragments

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Mar 08 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 03 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9248179

Pan-lyssavirus vaccines against rabies

The United States of America as represented by the Secretary of the Department of Health and Human Services, Centers for Disease Control and Prevention Β· Granted Tue Feb 02 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 28 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9228002

Leishmania vaccine using sand fly salivary immunogen

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Jan 05 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 31 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9222142

Adenoviruses and their use

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Dec 29 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 24 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9216214

Replication-competent adenoviral vectors

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Dec 22 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 17 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9217010

N-substituted indenoisoquinolines and syntheses thereof

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Dec 22 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 17 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9210925

Multipotent postnatal stem cells from human periodontal ligament and uses thereof

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Dec 15 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 10 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9198941

Yeast-Brachyury immunotherapeutic compositions

The United States of America as Represented by the Secretary, Dept. of Health and Human Services Β· Granted Tue Dec 01 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 26 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9193739

Induction of highly specific antibodies to a hapten but not to a carrier peptide by immuni

The United States of America as Represented by the Secretary, Dept. of Health and Human Services Β· Granted Tue Nov 24 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 19 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9187457

Low molecular weight thyroid stimulating hormone receptor (TSHR) agonists

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Nov 17 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 12 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9187516

Compositions and methods for inhibiting expression of a gene from the Ebola virus

The United States of America as represented by the Secretary of the Army Β· Granted Tue Nov 17 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 12 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9175264

Postnatal stem cells and uses thereof

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Nov 03 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 29 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9173932

Vibrio cholerae O139 conjugate vaccines

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Nov 03 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 29 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9175033

Methods for preparing complex multivalent immunogenic conjugates

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Nov 03 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 29 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9173917

Methods for reducing oxidative stress in a cell with a sulfhydryl protected glutathione pr

The United States of America as represented by the Department of Veteran Affairs Β· Granted Tue Nov 03 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 29 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9163244

Suppressors of CpG oligonucleotides and methods of use

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Oct 20 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 15 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9163236

Pharmaceutical composition comprising NANOG SHRNA, and method of using NANOG SHRNA to trea

The United States of America as Represented by the Secretary, Dept. of Health and Human Services Β· Granted Tue Oct 20 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 15 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9163068

Influenza virus recombinant proteins

The United States of America as Represented by The Secretary of the Department of Health and Human Services National Institutes of Health Office of Technology Transfer Β· Granted Tue Oct 20 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 15 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9132135

Method of treating organophosphorous poisoning

The United States of America as represented by the Secretary of the Army Β· Granted Tue Sep 15 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 10 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted